Gubbala Kumar, Laios Alex, Gallos Ioannis, Pathiraja Pubudu, Haldar Krishnayan, Ind Thomas
Gynaecologic Oncology Unit, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
Department of Gynaecologic Oncology, Royal Marsden Hospital NHS Trust, London, UK.
J Ovarian Res. 2014 Jun 25;7:69. doi: 10.1186/1757-2215-7-69. eCollection 2014.
Pelvic irradiation is essential for improving survival in women with pelvic malignancies despite inducing permanent ovarian damage. Ovarian transposition can be performed in premenopausal women in an attempt to preserve ovarian function. As uncertainty occurs over the proportion of women who are likely to benefit from the procedure, we performed a systematic review and meta-analysis of the proportion of women with ovarian function preservation, symptomatic or asymptomatic ovarian cysts and metastatic ovarian malignancy following ovarian transposition.
Medline, Embase and The Cochrane Library databases were systematically searched for articles published from January 1980 to December 2013. We computed the summary proportions for ovarian function preservation, ovarian cyst formation and metastatic ovarian disease following ovarian transposition by random effects meta-analysis with meta-regression to explore for heterogeneity by type of radiotherapy.
Twenty four articles reporting on 892 women undergoing ovarian transposition were included. In the surgery alone group, the proportion of women with preserved ovarian function was 90% (95% CI 92-99), 87% (95% CI 79-97) of women did not develop ovarian cysts and 100% (95% CI 90-111) did not suffer metastases to the transposed ovaries. In the brachytherapy (BR)± surgery group, the proportion of women with preserved ovarian function was 94% (95% CI 79-111), 84% (95% CI 70-101) of women did not develop ovarian cysts and 100% (95% CI 85-118) did not suffer metastases to the transposed ovaries. In the external beam radiotherapy (EBRT) +surgery ± BR group, the proportion of women with preserved ovarian function was 65% (95% CI 56-74), 95% (95% CI 85-106) of women did not develop ovarian cysts and 100% (95% CI 90-112) did not suffer metastases to the transposed ovaries. Subgroup meta-analysis revealed transposition to the subcutaneous tissue being associated with higher ovarian cyst formation rate compared to the "traditional" transposition.
Ovarian transposition is associated with significant preservation of ovarian function and negligible risk for metastases to the transposed ovaries despite common incidence of ovarian cysts.
盆腔放疗对于提高盆腔恶性肿瘤女性的生存率至关重要,尽管会导致永久性卵巢损伤。卵巢移位术可在绝经前女性中进行,以试图保留卵巢功能。由于对于可能从该手术中获益的女性比例存在不确定性,我们对卵巢移位术后卵巢功能保留、有症状或无症状卵巢囊肿以及卵巢转移性恶性肿瘤的女性比例进行了系统评价和荟萃分析。
系统检索Medline、Embase和Cochrane图书馆数据库中1980年1月至2013年12月发表的文章。我们通过随机效应荟萃分析计算卵巢移位术后卵巢功能保留、卵巢囊肿形成和卵巢转移性疾病的汇总比例,并进行荟萃回归以探讨放疗类型的异质性。
纳入了24篇报道892例行卵巢移位术女性的文章。在单纯手术组中,卵巢功能保留的女性比例为90%(95%CI 92 - 99),87%(95%CI 79 - 97)的女性未发生卵巢囊肿,100%(95%CI 90 - 111)的女性未发生移位卵巢转移。在近距离放疗(BR)±手术组中,卵巢功能保留的女性比例为94%(95%CI 79 - 111),84%(95%CI 70 - 101)的女性未发生卵巢囊肿,100%(95%CI 85 - 118)的女性未发生移位卵巢转移。在体外放疗(EBRT)+手术±BR组中,卵巢功能保留的女性比例为65%(95%CI 56 - 74),95%(95%CI 85 - 106)的女性未发生卵巢囊肿,100%(95%CI 90 - 112)的女性未发生移位卵巢转移。亚组荟萃分析显示,与“传统”移位相比,移位至皮下组织与较高的卵巢囊肿形成率相关。
卵巢移位术与显著保留卵巢功能相关,尽管卵巢囊肿发生率较高,但移位卵巢转移风险可忽略不计。